5 year study: Could token rewards improve HIV patient outcomes across Africa?

A blockchain healthcare provider and a Kenyan university will collaborate to examine whether crypto and blockchain technology can help Africa’s HIV crisis.
The groundbreaking five-year study to determine if crypto token incentives can improve HIV/AIDS patients’ health outcomes will be launched in Kenya this year. This will be done by Immunify.Life (@ImmunifyLife), December 1, 2021

MMUST will use Immunify.Life blockchain technology to collect and analyze patient data in order to improve HIV treatment outcomes. It will assess whether patients have better treatment outcomes if they receive token rewards for health-positive behavior identified by project sponsors, such as NGOs or government institutions. Guy Newing, CEO of Immunify.Life, told Cointelegraph that the program is being tested will offer token incentives to encourage patients to come to the clinic for treatment. Patients and doctors will be rewarded using Immunify.Life’s native ERC-20 token. These could be offered to patients for “completing a prescribed course in Tuberculosis antibiotics” and to encourage HIV-positive patients to return to the clinic for treatment. Newing also stated that Immunify.Life’s native ERC-20 IMM token will be used to reward doctors and patients. This token captures important medical data such as vaccination records. The data is then transferred into a digital registry for remote medical supervision and real time data access for doctors. 600 patients were included in the study. Half of the patients will be incentivized with tokens, while the other half will serve as controls and not receive token rewards. Half of the patients will receive the token incentivization, while the other half will act as controls and will not be eligible for token rewards. Immunify.Life is currently holding a private round of institutional and strategic investors prior to its initial DEX offering (IDO), which is scheduled for early 2022. Patients will have the ability to control their data and share in the financial benefits. The fees paid to healthcare providers and organizations that fund the system finance the system. Immunify.Life also works in HIV/AIDS in Kenya. According to the 2020 UNAIDS report, Kenya is home to approximately 1.5 million HIV-positive people. 70% of these patients receive treatment. However, there are difficulties in tracking, access, program design and data collection. Many HIV-positive people are unable or unwilling to continue their treatment. According to Immunify.Life, there can be as high as 40% of HIV-positive patients who have lapsed. This includes pregnant women who can transmit the virus to their child at birth.

Relevant news

Leave a Reply